Created at:1/13/2025
Acalabrutinib is a targeted cancer medication that helps treat certain types of blood cancers by blocking specific proteins that cancer cells need to grow and survive. This oral medication belongs to a class of drugs called BTK inhibitors, which work like a key that fits into a specific lock on cancer cells, stopping them from multiplying.
If you or someone you care about has been prescribed acalabrutinib, you're likely feeling a mix of hope and concern. That's completely natural. Understanding how this medication works and what to expect can help you feel more confident about your treatment journey.
Acalabrutinib is a precision cancer drug that targets a specific protein called Bruton's tyrosine kinase (BTK). Think of BTK as a switch that tells certain cancer cells to grow and spread. Acalabrutinib works by turning off this switch, which helps slow down or stop the cancer from getting worse.
This medication is what doctors call a "targeted therapy" because it focuses on specific parts of cancer cells rather than affecting all rapidly dividing cells in your body. This targeted approach often means fewer side effects compared to traditional chemotherapy, though every person's experience is unique.
The drug comes as capsules that you take by mouth, making it convenient for at-home treatment. Your healthcare team will monitor you closely while you're taking acalabrutinib to ensure it's working effectively and to manage any side effects that might occur.
Acalabrutinib is primarily used to treat specific types of blood cancers, particularly chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). These conditions involve white blood cells that don't function properly and can crowd out healthy blood cells.
Your doctor might prescribe acalabrutinib if you have CLL or SLL that has returned after other treatments or if you're newly diagnosed and other treatments aren't suitable for you. It's also used for mantle cell lymphoma, another type of blood cancer that affects lymph nodes and other organs.
The medication works best for cancers that have certain genetic characteristics. Your healthcare team will run specific tests on your cancer cells to determine if acalabrutinib is likely to be effective for your particular situation.
Acalabrutinib works by blocking the BTK protein, which is like a communication hub that cancer cells use to receive growth signals. When this protein is blocked, the cancer cells can't get the messages they need to survive and multiply.
This medication is considered a moderately strong targeted therapy. While it's powerful enough to effectively treat blood cancers, it's generally gentler on your body than traditional chemotherapy because it specifically targets cancer cells rather than all fast-growing cells.
The drug builds up in your system over time, so you'll need to take it consistently every day for it to work effectively. Most people start seeing results within a few weeks to months, though your doctor will monitor your progress through regular blood tests and check-ups.
Take acalabrutinib exactly as your doctor prescribes, typically twice daily about 12 hours apart. You can take it with or without food, but try to take it at the same times each day to help maintain steady levels in your body.
Swallow the capsules whole with water. Don't open, break, or chew them, as this can affect how the medication is absorbed. If you have trouble swallowing capsules, talk to your healthcare team about alternatives rather than trying to modify the capsules yourself.
It's important to avoid grapefruit and grapefruit juice while taking acalabrutinib, as they can increase the amount of medication in your blood to potentially dangerous levels. Your doctor will provide a complete list of foods and medications to avoid.
You'll likely take acalabrutinib for as long as it continues to work effectively and you're tolerating it well. For most people with blood cancers, this means taking it indefinitely, as stopping the medication could allow the cancer to start growing again.
Your healthcare team will regularly monitor your response to treatment through blood tests, imaging scans, and physical exams. These check-ups help determine if the medication is still working and if any adjustments need to be made to your treatment plan.
Some people may need to take breaks from acalabrutinib if they experience significant side effects. Your doctor will work with you to find the right balance between controlling your cancer and maintaining your quality of life.
Like all medications, acalabrutinib can cause side effects, though not everyone experiences them. Most side effects are manageable with proper care and monitoring from your healthcare team.
The most common side effects you might experience include headaches, diarrhea, muscle and joint pain, and fatigue. These effects often improve as your body adjusts to the medication, usually within the first few weeks of treatment.
Here are the more common side effects that patients report:
Most of these side effects are mild to moderate and can be managed with supportive care. Your healthcare team will provide specific strategies for dealing with each one.
Some less common but more serious side effects require immediate medical attention. While these occur in a smaller percentage of patients, it's important to know what to watch for.
Contact your healthcare provider right away if you experience:
These symptoms are manageable when caught early, so don't hesitate to reach out to your care team if you're concerned about any changes in how you feel.
Rarely, acalabrutinib can cause more serious complications that affect a very small percentage of patients. Your doctor will monitor you closely for these possibilities through regular testing and check-ups.
Acalabrutinib isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you based on your overall health and medical history. People with certain conditions may need alternative treatments or special monitoring.
You should not take acalabrutinib if you're allergic to it or any of its ingredients. Your healthcare team will review all your known allergies before prescribing this medication to ensure it's safe for you.
Your doctor will be extra cautious about prescribing acalabrutinib if you have:
These conditions don't automatically disqualify you from taking acalabrutinib, but they may require additional monitoring or dosage adjustments to ensure your safety.
If you're pregnant, planning to become pregnant, or breastfeeding, acalabrutinib is not recommended as it could harm your baby. Your healthcare team will discuss effective birth control methods if you're of childbearing age.
Acalabrutinib is sold under the brand name Calquence. This is the only brand name currently available for this medication, as it's a relatively new targeted therapy that was developed by AstraZeneca.
You might see both names used interchangeably in your medical records or prescription bottles. Whether your doctor refers to it as acalabrutinib or Calquence, they're talking about the same medication.
Generic versions of acalabrutinib are not yet available, so Calquence is currently the only option for obtaining this medication. Your insurance coverage and pharmacy benefits will determine your out-of-pocket costs for this brand-name medication.
If acalabrutinib isn't right for you or stops working effectively, several other treatment options are available for blood cancers. Your healthcare team will help you explore these alternatives based on your specific situation and medical history.
Other BTK inhibitors like ibrutinib (Imbruvica) and zanubrutinib (Brukinsa) work similarly to acalabrutinib but may have different side effect profiles. Some people tolerate one BTK inhibitor better than another, so switching between them is sometimes helpful.
Additional treatment options might include:
Your doctor will consider factors like your cancer's specific characteristics, your overall health, previous treatments, and personal preferences when recommending alternatives. The goal is always to find the most effective treatment with the fewest side effects for your unique situation.
Acalabrutinib and ibrutinib are both BTK inhibitors that work in similar ways, but they have some important differences that might make one more suitable for you than the other. Neither is universally "better" – the best choice depends on your individual circumstances.
Acalabrutinib is often considered to have fewer heart-related side effects compared to ibrutinib. Studies suggest that people taking acalabrutinib may experience less irregular heartbeat and high blood pressure, which can be important if you have existing heart conditions.
Both medications are similarly effective at treating blood cancers, but acalabrutinib may cause less diarrhea and joint pain in some people. However, individual responses vary, and what works best for one person may not be ideal for another.
Your doctor will help you weigh the potential benefits and risks of each option based on your medical history, current health status, and the specific characteristics of your cancer. The decision often comes down to which medication is most likely to give you the best quality of life while effectively treating your condition.
Q1:Is Acalabrutinib Safe for People with Heart Disease?
Acalabrutinib can generally be used safely in people with heart disease, though you'll need closer monitoring than someone without heart conditions. Studies suggest it causes fewer heart-related side effects compared to some other BTK inhibitors.
Your cardiologist and oncologist will work together to monitor your heart health while you're taking acalabrutinib. They may recommend regular heart function tests and blood pressure checks to ensure the medication isn't affecting your cardiovascular system.
If you have a history of irregular heartbeat or other heart rhythm problems, your healthcare team will weigh the benefits of cancer treatment against the potential risks to your heart. Often, the cancer treatment benefits outweigh the risks, especially with careful monitoring.
Q2:What Should I Do if I Accidentally Take Too Much Acalabrutinib?
If you accidentally take more acalabrutinib than prescribed, contact your healthcare provider or poison control center immediately. Don't wait to see if you feel symptoms, as getting guidance early is always safer.
Taking too much acalabrutinib could increase your risk of side effects like bleeding, irregular heartbeat, or severe diarrhea. Your healthcare team may want to monitor you more closely or provide supportive care to manage any symptoms that develop.
Keep your medication in a clearly labeled container and consider using a pill organizer to help prevent accidental overdoses. If you live with others, make sure they know not to take your medication, as it's specifically prescribed for your condition.
Q3:What Should I Do if I Miss a Dose of Acalabrutinib?
If you miss a dose of acalabrutinib and it's been less than 3 hours since your scheduled time, go ahead and take it. If it's been more than 3 hours, skip the missed dose and take your next scheduled dose at the regular time.
Don't take a double dose to make up for the missed one, as this could increase your risk of side effects. Instead, just continue with your regular dosing schedule and let your healthcare team know about the missed dose at your next appointment.
Setting phone alarms or using a medication reminder app can help you stay on track with your dosing schedule. Consistent timing helps maintain steady levels of the medication in your system for optimal effectiveness.
Q4:When Can I Stop Taking Acalabrutinib?
You should only stop taking acalabrutinib under the direct guidance of your healthcare team. For most people with blood cancers, this medication needs to be taken long-term to keep the cancer under control.
Your doctor will regularly assess whether acalabrutinib is still working effectively and if the benefits continue to outweigh any side effects you're experiencing. They may adjust your dose or temporarily pause treatment if needed, but stopping completely requires careful consideration.
If you're experiencing side effects that are affecting your quality of life, talk to your healthcare team about management strategies rather than stopping the medication on your own. Often, side effects can be managed while continuing effective cancer treatment.
Q5:Can I Drink Alcohol While Taking Acalabrutinib?
It's generally best to limit alcohol consumption while taking acalabrutinib, though small amounts may be acceptable depending on your overall health. Alcohol can potentially increase your risk of bleeding and may interfere with your body's ability to fight infections.
Talk to your healthcare team about what amount of alcohol, if any, is safe for you personally. They'll consider factors like your liver function, other medications you're taking, and your overall health status when making recommendations.
If you do choose to drink alcohol occasionally, pay attention to how it affects you, as acalabrutinib may change how your body processes alcohol. Always prioritize your health and cancer treatment over social drinking.